Atrium Therapeutics (RNA) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.8
-0.75
-0.7
-0.65

Details

Expected EPS
-0.7114
Actual EPS
-0.65
Surprise EPS
0.06
Surprise Percent
+8.63%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.65⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts